AVTH Financials 07/15/2014 23:13:23 AV Therapeuti
Post# of 4
AV Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development 333 73 -
Sales, General and Admin. 552 190 2
Non-Recurring Items - - -
Other 21 21 -
Operating Income (905) (284) (2)
Income From Continuing Operations
Add'l Income/Expense Items - (2) -
Earnings Before Interest and Tax (906) (286) (2)
Interest Expense - - -
Earnings Before Tax (906) (286) (2)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (906) (286) (2)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (906) (286) (2)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (906) (286) (2)